ALT - Altimmune Inc
IEX Last Trade
6.7
0.090 1.343%
Share volume: 1,452,851
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.61
0.09
1.36%
Summary score
13%
Profitability
8%
Dept financing
5%
Liquidity
50%
Performance
11%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
13.5%
Return on assets
-7.47%
Return on sales
0%
Return on invested capital
-676.47%
Total debt ratio
22.01%
Debt ratio change over timeo
-1.83%
Current Ratio
9.72%
Quick Ratio
0%
Cash Position Ratio
6.09%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.38%
Return on assets
-10.67%
Return on sales
0%
Return on invested capital
-86.54%
Total debt ratio
18.35%
Debt ratio change over timeo
-1.43%
Current Ratio
12.84%
Quick Ratio
0%
Cash Position Ratio
5.45%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-21.08%
Return on assets
-6.36%
Return on sales
0%
Return on invested capital
-173.64%
Total debt ratio
22.45%
Debt ratio change over time
-1.49%
Current Ratio
17.89%
Quick Ratio
0%
Cash Position Ratio
13.17%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
52.77%
Return on assets
-67.65%
Return on sales
0%
Return on invested capital
516.68%
Total debt ratio
-183.12%
Debt ratio change over time
-1.83%
Current Ratio
-33.51%
Quick Ratio
0%
Cash Position Ratio
-24.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 13.5% | -3.05% | 11.55% | 6.27% |
| Return on assets | -7.47% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -676.47% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 46% | 78% | 81% |
| Total debt ratio | 22.01% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.83% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 12.84% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 5.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 17% | 37% | 38% |
| Short-term ratios | ALT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.38% | -25.62% | 17.94% | 7.14% |
| Return on assets | -10.67% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -86.54% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 18.35% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.43% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 12.84% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 5.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 28% | 22% | 39% |